Skip to content
10-Q

Quarterly Report

BIOZOOM, INC.

0001517126-13-000032

← back to feed
Filed
Feb 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Feb 18, 2013 59.73M sh
Shares Diluted Q3 2012 · Dec 31, 2012 59.73M sh
Shares Diluted Q3 2012 · Dec 31, 2012 59.73M sh
Shares Diluted Q3 2012 · Dec 31, 2012 59.73M sh
Shares Diluted Q3 2012 · Dec 31, 2011 59.73M sh
Shares Diluted Q3 2012 · Dec 31, 2011 59.73M sh
Operating Cash Flow Q3 2012 · Dec 31, 2012 −$11.44K
Operating Cash Flow Q3 2012 · Dec 31, 2012 −$175.6K
Operating Cash Flow Q3 2012 · Dec 31, 2011 −$27.24K
Stockholders Equity Q3 2012 · Dec 31, 2012 −$18.49K
Stockholders Equity Q3 2012 · Mar 31, 2012 −$84.95K
Current Liabilities Q3 2012 · Dec 31, 2012 $18.49K
Current Liabilities Q3 2012 · Mar 31, 2012 $87.89K
Total Liabilities Q3 2012 · Dec 31, 2012 $18.49K
Total Liabilities Q3 2012 · Mar 31, 2012 $87.89K
Current Assets Q3 2012 · Dec 31, 2012 $0
Current Assets Q3 2012 · Mar 31, 2012 $2.94K
Total Assets Q3 2012 · Dec 31, 2012 $0
Total Assets Q3 2012 · Mar 31, 2012 $2.94K
Net Income Q3 2012 · Dec 31, 2012 $80.13K
Net Income Q3 2012 · Dec 31, 2012 $66.6K
Net Income Q3 2012 · Dec 31, 2012 −$84.59K
Net Income Q3 2012 · Dec 31, 2011 $27.69K
Net Income Q3 2012 · Dec 31, 2011 $10.02K
Operating Income Q3 2012 · Dec 31, 2012 −$8.41K
Operating Income Q3 2012 · Dec 31, 2012 −$20.58K
Operating Income Q3 2012 · Dec 31, 2012 −$197.51K
Operating Income Q3 2012 · Dec 31, 2011 −$3.43K
Operating Income Q3 2012 · Dec 31, 2011 −$18.35K
Cost Of Revenue Q3 2012 · Dec 31, 2012 $0
Cost Of Revenue Q3 2012 · Dec 31, 2012 $0
Cost Of Revenue Q3 2012 · Dec 31, 2012 $1.5K
Cost Of Revenue Q3 2012 · Dec 31, 2011 $0
Cost Of Revenue Q3 2012 · Dec 31, 2011 $0
Revenue Q3 2012 · Dec 31, 2012 $0
Revenue Q3 2012 · Dec 31, 2012 $0
Revenue Q3 2012 · Dec 31, 2012 $0
Revenue Q3 2012 · Dec 31, 2011 $0
Revenue Q3 2012 · Dec 31, 2011 $0
Cash And Equivalents Q3 2012 · Mar 31, 2012 $2.94K
Cash And Equivalents Q3 2012 · Mar 31, 2011 $13
Cash And Equivalents Q3 2012 · Jun 14, 2007 $0